Onesource Specialty Pharma Limited — Updates, 11-06-2025: Press Release

OneSource Specialty Pharma has partnered with Sweden’s Xbrane Biopharma to manufacture biosimilars at its Bangalore facility, aiding Xbrane’s global supply chain and boosting OneSource’s biologics regulatory progress. The company also invested in Xbrane’s recent funding round, reinforcing strategic ties. This collaboration sets OneSource up to scale high-quality biosimilars globally, tapping into a EUR 23 billion biosimilars market, and strengthens its position as a preferred CDMO for biotech firms.